foscarnet has been researched along with Duncan Disease in 5 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lymphoproliferative disorders are usually treated with a combination of cytotoxic drugs, and virustatic medication is thought to be ineffective." | 5.31 | Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. ( Delecluse, HJ; Huhn, D; Ruhnke, M; Schneider, U; Stein, H, 2000) |
| "Chronic active EBV infections (CAEBV) are often causative of malignant lymphoproliferative disorders, such as natural killer (NK) cell-lineage granular lymphocyte proliferative disorders (NK-GLPD), which are refractory to several conventional chemotherapies and usually show a poor prognosis." | 1.32 | Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders. ( Ishii, M; Ishii, T; Kawase, I; Kimura, H; Mori, KL; Morishima, T; Ohshima, S; Saeki, Y; Yamaguchi, N, 2003) |
| "The lymphoproliferative disorders are usually treated with a combination of cytotoxic drugs, and virustatic medication is thought to be ineffective." | 1.31 | Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. ( Delecluse, HJ; Huhn, D; Ruhnke, M; Schneider, U; Stein, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, M | 1 |
| Yamaguchi, N | 1 |
| Ohshima, S | 1 |
| Ishii, T | 1 |
| Mori, KL | 1 |
| Kimura, H | 1 |
| Morishima, T | 1 |
| Kawase, I | 1 |
| Saeki, Y | 1 |
| Zhang, SH | 1 |
| Zhou, XG | 1 |
| Yu, XM | 1 |
| Wang, C | 1 |
| Huang, SF | 1 |
| Lusso, P | 1 |
| Gallo, RC | 1 |
| Oertel, SH | 1 |
| Ruhnke, MS | 1 |
| Anagnostopoulos, I | 1 |
| Kahl, AA | 1 |
| Frewer, AF | 1 |
| Bechstein, WO | 1 |
| Hummel, MW | 1 |
| Riess, HB | 1 |
| Schneider, U | 1 |
| Ruhnke, M | 1 |
| Delecluse, HJ | 1 |
| Stein, H | 1 |
| Huhn, D | 1 |
1 review available for foscarnet and Duncan Disease
| Article | Year |
|---|---|
Human herpesvirus 6.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antibodies, Viral; Base Sequence; Child; Child, | 1995 |
4 other studies available for foscarnet and Duncan Disease
| Article | Year |
|---|---|
Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders.
Topics: Adolescent; Animals; Antiviral Agents; Cell Division; Chronic Disease; Culicidae; Epstein-Barr Virus | 2003 |
[Post-transplant lymphoproliferative disorders following allogenic bone marrow transplantation].
Topics: Adult; Antigens, CD20; Antiviral Agents; Bone Marrow Transplantation; CD3 Complex; Epstein-Barr Viru | 2005 |
Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation.
Topics: Antiviral Agents; Foscarnet; Heart Transplantation; Herpesvirus 4, Human; Humans; Infectious Mononuc | 1999 |
Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Epstein-Barr Virus Infections; Foscarne | 2000 |